Effect of Neoadjuvant Chemoradiation and Surgical Technique on Recurrence of Localized Pancreatic Cancer
- 555 Downloads
To determine the influence of neoadjuvant chemoradiation and standardized dissection of the superior mesenteric artery upon the oncologic outcome of patients with localized pancreatic adenocarcinoma.
One hundred ninety-four patients with pancreatic adenocarcinoma who underwent pancreaticoduodenectomy between 2004 and 2008 were evaluated. The retroperitoneal dissection was performed directly along the superior mesenteric artery in all cases. A standard histopathologic protocol that measured the “superior mesenteric artery (SMA) margin distance” between cancer cells and the superior mesenteric artery was employed.
Seventy-six percent of patients received neoadjuvant chemoradiation. The SMA margin was positive in 4% of patients but an additional 22% of patients with a negative margin had a SMA margin distance of ≤1 mm. Preoperative CT images overestimated the SMA margin distance in 73% of cases. Patients who received chemoradiation had longer SMA margin distances than those who did not. Patients who received chemoradiation and had a SMA margin of >1 mm had the lowest recurrence rates. Administration of neoadjuvant chemoradiation and lower estimated blood loss were independently associated with longer progression-free survival on multivariate analysis.
Preoperative chemoradiation and meticulous dissection of the superior mesenteric artery maximize the distance between cancer cells and the SMA margin and may influence locoregional control.
KeywordsPancreatic cancer Mesopancreas Chemoradiation Pancreaticoduodenectomy SMA margin Surgery
We thank Henry Gomez, MD, manager of the Pancreatic Tumor Database at the University of Texas MD Anderson Cancer Center.
- 9.Klinkenbijl JH, Jeekel J, Sahmoud T et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Annals of Surgery 1999; 230: 776–782; discussion 782–774.Google Scholar
- 13.Katz MH, Pisters PW, Evans DB et al. Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. J Am Coll Surg 2008; 206: 833–846; discussion 846–838.Google Scholar
- 16.Gaedcke J, Gunawan B, Grade M et al. The mesopancreas is the primary site for R1 resection in pancreatic head cancer: relevance for clinical trials. Langenbeck's archives of surgery / Deutsche Gesellschaft fur Chirurgie 2010; 395: 451–458.Google Scholar
- 19.Gerard JP, Azria D, Gourgou-Bourgade S et al. Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010; 28: 1638–1644.CrossRefGoogle Scholar
- 24.Yen TW, Abdalla EK, Pisters PW, Evans DB. Pancreaticoduodenectomy. In Von Hoff DD, Evans DB, Hruban RH (eds): Pancreatic cancer. Sudbury: Jones and Bartlett 2005; 265–286.Google Scholar
- 25.Exocrine pancreas. In Edge SB, Byrd DR, Compton CC et al. (eds): AJCC Cancer Staging Manual, 7th Edition. Chicago: Springer 2009; pp 241–249.Google Scholar
- 26.Exocrine pancreas. In Greene FL, Page DL, Fleming ID et al. (eds): AJCC Cancer Staging Manual, 6th Edition. Chicago: Springer 2002; 157–164.Google Scholar
- 27.Tseng JF, Raut CP, Lee JE et al. Pancreaticoduodenectomy with vascular resection: margin status and survival duration. Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract 2004; 8: 935–949; discussion 949–950.Google Scholar
- 32.Winter JM, Cameron JL, Campbell KA et al. 1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience. Journal of Gastrointestinal Surgery: Official Journal of the society for Surgery of the Alimentary Tract 2006; 10: 1199–1210; discussion 1210–1191.Google Scholar
- 34.Baque P, Iannelli A, Delotte J et al. Division of the right posterior attachments of the head of the pancreas with a linear stapler during pancreaticoduodenectomy: vascular and oncological considerations based on an anatomical cadaver-based study. Surgical and radiologic anatomy : SRA 2009; 31: 13–17.PubMedCrossRefGoogle Scholar
- 35.Van den Broeck A, Sergeant G, Ectors N et al. Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2009; 35: 600–604.CrossRefGoogle Scholar
- 36.Pancreas (exocrine). In Pathologists CoA (ed) College of American Pathologists Cancer Protocols. 2009.Google Scholar